Exploring Treatment Modalities for Foot Equinus in Cerebral Palsy: A Comparative Analysis of Surgical Release and Botulinum Toxin Injections
Main Article Content
Abstract
Objective: To provide important insights into the relative efficacies of these two therapy techniques for controlling foot equines in the context of cerebral palsy patients, the study aims to compare and contrast their distinct outcomes.
Method: The effectiveness of the intervention was examined in two separate groups, based on gender and age, using a cross-sectional study methodology. There were thirty volunteers in each group, out of a total of sixty, for the study. The distribution of genders and age groups, as well as the effectiveness of the interventions, was methodically documented. Potential correlations and variations were investigated using statistical analysis, such as chi-square tests and mean computations. Participants were informed about the nature and goal of the intervention, and the study complied with ethical guidelines.
Result: There was no discernible difference between groups (A and B) according to the gender distribution analysis (Table 1), suggesting that the proportion of men and women in both groups was pretty balanced. However, there were slight variations in the efficacy assessments for both the male and female categories. There were no statistically significant differences between groups (A & B) in the age distribution (Table 2). Notably, Table 3's overall effectiveness of the intervention showed a significant difference (p = 0.029) between the two groups. Subsequent examination of age-specific efficacy (Table 4) did not show any discernible variations throughout age groups.
Conclusion: This study indicates that age does not seem to be a relevant determinant, even though gender may have some bearing on the intervention's efficacy. There were differences in the overall effectiveness of the intervention between groups A and B. These findings highlight the significance of taking age and gender into account when evaluating treatment outcomes and offer insightful information about the complex elements of the intervention's influence across various demographic parameters. Larger sample numbers in future studies could lead to a deeper comprehension of these connections.
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Marvulli R, Megna M, Citraro A, Vacca E, Napolitano M, Gallo G, et al. Botulinum toxin type A and physiotherapy in spasticity of the lower limbs due to amyotrophic lateral sclerosis. Toxins (Basel) 2019;11(7):381. DOI: 10.3390/toxins11070381.
Rezasoltani Z, Azizi S, Najafi S, Sanati E, Dadarkhah A, Abdorrazaghi F. Physical therapy, intra-articular dextrose prolotherapy, botulinum neurotoxin, and hyaluronic acid for knee osteoarthritis: randomized clinical trial. Int J Rehabil Res 2020;43(3):219-27. DOI: 10.1097/MRR.0000000000000411.
Nasb M, Li Z, Youssef ASA, Dayoub L, Chen H. Comparison of the effects of modified constraint-induced movement therapy and intensive conventional therapy with a botulinum-a toxin injection on upper limb motor function recovery in patients with stroke. Libyan J Med 2019;14(1):1609304. DOI: 10.1080/19932820.2019.1609304.
Vidal X, Martí-Fàbregas J, Canet O, Roque M, Morral A, Tur M, et al. Efficacy of radial extracorporeal shock wave therapy compared with botulinum toxin type A injection in treatment of lower extremity spasticity in subjects with cerebral palsy: a randomized, controlled, cross-over study. J Rehabil Med 2020;52(6): jrm00076. DOI: 10.2340/16501977-2703.
Wang L, Xu L, Liu G, et al. Meta-analysis of selective posterior rhizotomy in children with cerebral palsy. Orthop J China 2022;30(15):1372-6.
Eleopra R, Rinaldo S, Montecucco C, Rossetto O, Devigili G. Clinical duration of action of different botulinum toxin types in humans. Toxicon 2020; 179:84-91. DOI: 10.1016/j.toxicon.2020.02.020.
Francisco GE, Bandari DS, Bavikatte G, Jost WH, McCusker E, Largent J, et al. High clinician- and patient-reported satisfaction with individualized onabotulinumtoxin A treatment for spasticity across several etiologies from the ASPIRE study. Toxicon X 2020;7: 100040. DOI: 10.1016/j.toxcx.2020.100040.
Mathevon L, Bonan I, Barnais JL, Boyer F, Dinomais M. Adjunct therapies to improve outcomes after botulinum toxin injection in children: a systematic review. Ann Phys Rehabil Med 2019;62(4):283-90. DOI: 10.1016/j.rehab.2018.06.010.
Jia X, Qiang M, Chen Y, Zhang K, Chen S. The influence of selective arthrodesis on a three-dimensional range of motion of the hindfoot joint: a cadaveric study. Clin Biomech (Bristol, Avon) 2019;69:9-15.
Lennon N, Church C, Chua T, et al. Is standing function improved after orthopaedic surgery in children with cerebral palsy at GMFCS levels III/IV? J Pediatr Orthop 2023;43(1): e48-53.
De Beukelaer N, Weide G, Huyghe E, et al. Reduced cross-sectional muscle growth six months after botulinum toxin type-A injection in children with spastic cerebral palsy. Toxins 2022;14(2):139.
Liu JJ, Zhang Y, Qi J, Zeng FY, Li NL. Effect of rehabilitation on the long-term efficacy of botulinum toxin-A for spastic cerebral palsy. Eur Rev Med Pharmacol Sci 2022;26(11):3927-32.
Gao BQ, Yang WL, Wang YJ, Tian ZX, Deng YX. Clinical study of CBTX-A in the treatment of spastic cerebral palsy. Chin J Neuromed 2005; 5:488-90.
Peeters N, Hanssen B, Cenni F, et al. O 019 - do botulinum toxin-A and lower leg casting alter calf muscle and tendon lengths in children with spastic cerebral palsy? Gait Posture 2018; 65:36-8.
Peeters N, Van Campenhout A, Hanssen B, et al. Joint and muscle assessments of the separate effects of botulinum neurotoxin-A and lower-leg casting in children with cerebral palsy. Front Neurol 2020; 11:210